Literature DB >> 34425210

Helicobacters and cancer, not only gastric cancer?

Christine Varon1, Lamia Azzi-Martin2, Sadia Khalid3, Lornella Seeneevassen1, Armelle Ménard1, Pirjo Spuul4.   

Abstract

The Helicobacter genus actually comprises 46 validly published species divided into two main clades: gastric and enterohepatic Helicobacters. These bacteria colonize alternative sites of the digestive system in animals and humans, and contribute to inflammation and cancers. In humans, Helicobacter infection is mainly related to H. pylori, a gastric pathogen infecting more than half of the world's population, leading to chronic inflammation of the gastric mucosa that can evolve into two types of gastric cancers: gastric adenocarcinomas and gastric MALT lymphoma. In addition, H. pylori but also non-H. pylori Helicobacter infection has been associated with many extra-gastric malignancies. This review focuses on H. pylori and its role in gastric cancers and extra-gastric diseases, as well as malignancies induced by non-H. pylori Helicobacters. Their different virulence factors and their involvement in carcinogenesis is discussed. This review highlights the importance of both gastric and enterohepatic Helicobacters in gastrointestinal and liver cancers.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytolethal distending toxin; Cytotoxin-associated gene A; Enterohepatic Helicobacters; Gastric cancer; Helicobacter pylori; Liver cancer

Year:  2021        PMID: 34425210     DOI: 10.1016/j.semcancer.2021.08.007

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   17.012


  7 in total

Review 1.  Hippo in Gastric Cancer: From Signalling to Therapy.

Authors:  Lornella Seeneevassen; Pierre Dubus; Caroline Gronnier; Christine Varon
Journal:  Cancers (Basel)       Date:  2022-05-03       Impact factor: 6.575

2.  Nomograms Involving HER2 for Predicting Lymph Node Metastasis in Early Gastric Cancer.

Authors:  Yu Mei; Shuo Wang; Tienan Feng; Min Yan; Fei Yuan; Zhenggang Zhu; Tian Li; Zhenglun Zhu
Journal:  Front Cell Dev Biol       Date:  2021-12-24

3.  Identifying Optimal Surgical Intervention-Based Chemotherapy for Gastric Cancer Patients With Liver Metastases.

Authors:  Min Sun; Hangliang Ding; Zhiqiang Zhu; Shengsheng Wang; Xinsheng Gu; Lingyun Xia; Tian Li
Journal:  Front Oncol       Date:  2021-11-29       Impact factor: 6.244

4.  MiR-1224 Acts as a Prognostic Biomarker and Inhibits the Progression of Gastric Cancer by Targeting SATB1.

Authors:  Guo-Dong Han; Yuan Sun; Hong-Xia Hui; Ming-Yue Tao; Yang-Qing Liu; Jing Zhu
Journal:  Front Oncol       Date:  2021-09-17       Impact factor: 6.244

5.  Adjuvant Chemotherapy in pT2N0M0 Gastric Cancer: Findings From a Retrospective Study.

Authors:  Yu Mei; Xijia Feng; Tienan Feng; Min Yan; Zhenggang Zhu; Tian Li; Zhenglun Zhu
Journal:  Front Pharmacol       Date:  2022-02-17       Impact factor: 5.810

6.  Does Intraoperative Blood Loss Affect the Short-Term Outcomes and Prognosis of Gastric Cancer Patients After Gastrectomy? A Meta-Analysis.

Authors:  Ze-Lin Wen; Da-Chun Xiao; Xiong Zhou
Journal:  Front Surg       Date:  2022-06-14

7.  The relationship between Helicobacter pylori and pancreatic cancer: a meta-analysis.

Authors:  Wei Xu; Xiaochong Zhou; Minyue Yin; Jingwen Gao; Zhen Weng; Chunfang Xu
Journal:  Transl Cancer Res       Date:  2022-08       Impact factor: 0.496

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.